Esp
PortILAR OTC Group Event – CDMX 2019
Sorry, but you do not have permission to view this content.
22Oct
Related Posts
22Oct
COFEPRIS announces the revocation of advertising criteria and guidelines
In accordance with article 4 of the Federal Law of Administrative... read more
22Oct
ANVISA opens public consultation to update the list of over-the-counter medications
On September, ANVISA published in the Journal of the Union... read more
13Aug
México: Self-care as an element of Public Health Policies and the framework of a new reality.
For the World Self-Care Day AFAMELA with the support of ILAR,... read more
06Nov
Reunión del Grupo OTC de ILAR en Washington DC
Los dias 4 y 5 de diciembre 2017, ILAR celebró la... read more
01Aug
Juan Carlos Thompson, appointed Director General of ILAR, effective as of August 1, 2017
The Latin American Association of Non-Prescription Drugs (ILAR) announced the appointment... read more
22Oct
Brazil establishes automatic conciliation of drug registration that has been authorized by the health authorities of other countries
The bill of law 3847/2019 created by Congress General Paternell (PSL)... read more
14Aug
Chile: how health systems in Latin America can sustainably benefit from self-care as a public policy
For the Self-care Day in Chile articles were published in seven newspapers,... read more
10Nov
Participación de ILAR en la III Conferencia Latinoamericana de Nicholas Hall sobre OTCs
Los dias 8 y 9 de Noviembre, el Director General de... read more
28Oct
ILAR participated in the Health Forum and 26th Pharmaceutical Forum of the ANDI, Colombia, held in Cartagena.
This Forum is the space that summons all health actors around... read more